Abstract: Unlike most other effector cells of the innate, as well as the adaptive immune systems, the neutrophil is a relatively undiscerning aggressor with scant regard for damage limitation. Although this highly combative, professional phagocyte has become increasingly implicated in the immunopathogenesis of many acute and chronic infl ammatory disorders, of both infective and noninfective origin, effective pharmacological strategies to counter neutrophil aggression have remained elusive. Activation of neutrophils results in rapid mobilization of both stored and extracellular Ca 2+ , resulting in abrupt, usually transient increases in cytosolic Ca
Introduction
Polymorphonuclear leukocytes, of which the neutrophil granulocyte is the most abundant, are key components of the innate immune system. These cells are activated and recruited to sites of infection by infl ammatory stimuli generated by microbial pathogens, or by the interaction of these with pattern recognition molecules present on/in neighboring tissue cells such as epithelial cells, mast cells and tissue macrophages. Notwithstanding their abruptly mobilizable arsenal of antimicrobial agents, which include antimicrobial peptides/proteins, enzymes, bioactive lipids, and reactive oxidant species (ROS) (Anderson et al 1998; Theron et al 2002; Hatanaka et al 2004) , these cells also have biosynthetic capability, albeit limited (Cassatella 1999; WitkoSarsat et al 2000) , which enables them to produce chemokines/cytokines, especially interleukin-8 (IL-8) and tumor necrosis factor-alpha (TNF-α). Acting in concert, TNF-α and IL-8 amplify neutrophil-mediated infl ammatory responses by promoting extravasation and accumulation of neutrophils at sites of tissue injury and infection through induction and upregulation of expression of endothelial adhesion molecules and chemotaxis, respectively. Neutrophil migration and localization are further potentiated by leukotriene B 4 (LTB 4 ), an endogenously generated bioactive lipid with potent chemoattractant activity (Chen et al 2006) .
Although extremely effective in eradicating microbial pathogens, the neutrophil, with its arsenal of indiscriminate oxidants and proteases, poses a potential threat to bystander host cells and tissues in the vicinity of the infl ammatory reaction. Accordingly, neutrophil infl ux must be effi cient, protective and promptly downregulated. Nevertheless, there is increasing awareness of the involvement of inappropriate activation of neutrophils in the etiology of many acute/hyper acute and chronic infl ammatory disorders of both infective and noninfective origin, important examples of which are shown in Figure 1 , with the airways and cardiovascular system being particularly vulnerable.
Responsiveness to corticosteroids
Few currently available therapeutic agents, including corticosteroids, effectively control the harmful pro-infl ammatory activities of neutrophils. Indeed, insensitivity to corticosteroids appears to be a feature of those disorders in which the neutrophil is the predominant offender.
The apparent insensitivity of neutrophils is attributable to the coexistence of several different resistance mechanisms in these cells. Firstly, in contradistinction to other types of immune and infl ammatory cells, glucocorticoids delay neutrophil apoptosis. This antiapoptotic effect of glucocorticoids in neutrophils is achieved by a mechanism which involves sustained expression of the antiapoptotic Bcl-2 family protein, Mcl-1L (Sivertson et al 2007) . Secondly, neutrophils contain high levels of the functionally inactive beta isoform of the glucocorticoid receptor (GR), the synthesis of which is further upregulated on exposure of the cells to IL-8 (Strickland et al 2001) , rendering them even less sensitive to corticosteroids.
Although not yet described in neutrophils, the activity of the enzyme histone deacetylase, which is recruited by activated GRs as a mechanism of repression of expression of multiple infl ammatory genes, is decreased in macrophages and circulating mononuclear leukocytes of patients with COPD and severe asthma respectively (reviewed in Barnes 2007) . Thirdly, many of the proinfl ammatory activities of neutrophils, including generation of ROS, release of granule proteases, and generation of prostanoids, eicosanoids, and platelet-activating factor (PAF) occur within seconds of receptor-mediated activation of these cells and are independent of de novo protein synthesis.
Clearly the identifi cation of novel targets for effective neutrophil-directed anti-infl ammatory chemotherapy is a priority.
Calcium and neutrophils
Interaction of neutrophil membrane receptors with chemoattractants, opsonized particles, or endothelial adhesion molecules, results in abrupt, transient increases in cytosolic Ca 2+ which precede, and are a prerequisite, for initiation of the proinfl ammatory activities of these cells. Ca 2+ -activatible infl ammatory functions include generation of superoxide by the membrane-associated electron transporting NADPH oxidase, adhesion to vascular endothelium, degranulation, activation of cytosolic phospholipase A 2 and 5-lipoxygenase, as well as synthesis of IL-8. Because of this critical dependence of activation of the proinfl ammatory activities of neutrophils on Ca 2+ , the mechanisms utilized by these cells to mobilize and dispose of the cation represent attractive, and in several cases, novel potential targets for neutrophil-directed antiinfl ammatory chemotherapy.
Calcium handling by activated neutrophils
A model of calcium mobilization and restoration of calcium homeostasis in activated human neutrophils is presented in Figure 2 and Figure 1 Activation of neutrophils by chemoattractants such as FMLP, PAF, C5a, and LTB 4 increases cytosolic Ca 2+ concentrations with resultant generation of toxic reactive oxygen species (ROS) and release of proteases, matrix metalloproteinases (MMPs) and lipid mediators. The tissue injury that may be associated with release of these harmful molecules into the vicinity of innocent bystander host tissues contributes to the pathogenesis of numerous diseases, including chronic obstructive pulmonary disease (COPD) and the acute respiratory distress syndrome (ARDS). Abbreviations: FMLP, N-formylated peptides/polypeptides; LTB 4 , leukotriene B 4 ; PAF, platelet-activating factor. (Favre et al 1996) . The receptors for the aforementioned chemoattractants belong to the 7-transmembrane, G-protein-coupled family of receptors. Occupation of these receptors, which are regulated by various Gα and Gβγ subunits, results in activation of the β isoforms of phospholipase C (PLC), which in turn mediate production of inositol-1,4,5-triphosphate (IP 3 ) by hydrolysis of phosphatidylinositol-4,5,-biphosphate (Ali et al 1998; Yue et al 1998 , are determined by at least 4 mechanisms. These are: i) shuttling of Ca 2+ between the stores and the cytosol (ie, repetitive bouts of release from, and resequestration of Ca 2+ into stores (Anderson et al 2005) ; ii) activation of a secondary wave of Ca 2+ infl ux due to endogenously-generated LTB 4 by chemoattractant-activated neutrophils (Steel et al 2007) ; iii) the effi ciency of the systems which promote clearance of Ca 2+ from the cytosol (Anderson et al 1998; Steel and Anderson 2002) ; and iv) the effi ciency of the systems which regulate the time of onset, rate and magnitude of infl ux of extracellular cation (Tintinger et al 2001a) .
Restoration of Ca 2+ homeostasis
Rapid and effi cient removal of Ca 2+ from the cytosol of activated neutrophils ensures that activation of the cells is brief, thereby avoiding Ca 2+ overload and hyperreactivity. This is achieved primarily by removal of Ca 2+ from the cytosol by two adenosine triphosphate (ATP)-driven Ca 2+ pumps operating in unison. These are the plasma membrane Ca 2+ -ATPase and the endomembrane Ca 2+ -ATPase, which mediate Ca 2+ effl ux and resequestration respectively. These two Ca 2+ pumps appear to contribute equally to the removal of Ca 2+ from the cytosol of activated neutrophils (Anderson and Goolam Mahomed 1997; Pettit and Hallett 2000) .
The plasma membrane Ca 2+ -ATPase of neutrophils is upregulated by calmodulin, acidic phospholipids, and polyunsaturated fatty acids, all of which shift the pump to a higher affi nity for Ca 2+ , resulting in enhanced maximal velocity (Carafoli et al 1992) .
Apart from causing activation of PLC and release of stored Ca 2+ , activation of neutrophils with chemoattractants such as FMLP is also accompanied by transient activation of adenylate cyclase (Iannone et al 1989; Theron et al 2002) .This results from the interaction of adenosine, generated by dephosphorylation of adenylates, presumably by ecto-5'nucleotidase, with G-protein/ adenylyl cyclase-coupled adenosine receptors (AR) of the A2 A subtype on the neutrophil membrane (Iannone et al 1989; Theron et al 2002) , resulting in activation of adenosine 3',5'-cyclic monophosphate (cAMP)-dependent protein kinase A (PKA). Phospholamban, a polypeptide regulator of the endomembrane Ca 2+ -ATPase, undergoes PKA-mediated phosphorylation which results in up-regulation of the Ca 2+ sequestering/resequestering activity of the pump (Chu et al 2000) .
Importantly , in the setting of a gradual infl ux of Ca 2+ , the rate of which is superimposable on that of membrane repolarization (Tintinger and Anderson 2004) .
While the magnitude and duration of the maximal membrane depolarization responses of neutrophils activated with FMLP are determined by the intensity and duration of activation of NADPH oxidase, as well as by the counteracting effects of an effl ux of protons from the cells (Schrenzel et al 1998; Bánfi et al 2000) , until relatively recently less was known about the mechanisms which contribute to membrane repolarization. We have identifi ed a role for the electrogenic Na + /Ca 2+ exchanger operating in reverse mode in mediating membrane repolarization in activated neutrophils (Tintinger and Anderson 2004) .
As opposed to being a major transporter of extracellular Ca 2+ for store refi lling, the primary role of the exchanger when operating in reverse mode is to mediate recovery of the membrane potential which is necessary to drive the infl ux of Ca 2+ through store-operated Ca 2+ channels (Tintinger and Anderson 2004) . However, the Na + /Ca 2+ exchanger is vulnerable to oxidative inactivation, being sensitive to the phagocyte-derived oxidants, hydrogen peroxide, and especially hypochlorous acid (Coetzee et al 1994; Tintinger et al 2007) . The effi ciency of the exchanger in activated neutrophils is therefore dependent on its level of exposure to phagocyte-derived oxidants.
Store-operated Ca 2+ channels
Until very recently, the precise molecular identity of the store-operated Ca 2+ channels operative in human neutrophils and other cell types had not been conclusively established. One particular family of nonvoltage-activated Ca 2+ channels which had attracted considerable attention and interest was the family of transient receptor potential (TRP) channels (Elliot 2001; Li et al 2002) . Although two members of this family, LTFP2 and TRP6, have been described in neutrophils (Li et al 2002; Heiner et al 2003) , the characteristics of these channels are not entirely compatible with those of putative, prototype store-operated Ca 2+ channels. However, in the past two years the identities of the major components of store-operated Ca 2+ channels have been elucidated. These are the proteins Stim1 (and possibly Stim2), and Orai1 (and possibly Orai2 and 3), which function as the Ca 2+ sensing and channel-forming proteins, respectively (Spassova et al 2006) . Stim1 is located in the endoplasmic reticulum where it binds reversibly to Ca 2+ . Following store depletion, dissociation of Ca 2+ causes Stim1 to redistribute within the endoplasmic reticulum to areas which are in close proximity to Orai1 within the plasma membrane. Stim1 then activates the Ca 2+ -selective Orai channels by a mechanism which remains to be elucidated (reviewed by Putney 2007).
Neutrophil-directed anti-infl ammatory strategies
Notwithstanding the increasing awareness of the antiinfl ammatory potential of macrolide antimicrobial agents (Simpson et al 2008) , several other categories of antiinfl ammatory agents have recently been described which have the potential to target neutrophils. These agents, described in detail elsewhere (Barnes 2007) , include: i) antagonists of receptors for chemoattractants such as C5a, IL-8, and LTB 4 ; ii) antagonists of endothelial adhesion molecules; iii) inhibitors of pro-infl ammatory enzymes and transcription factors such as phosphoinositide 3-kinase, 38 mitogen-activated protein kinase, and nuclear factor kappa B; and iv) activators of histone deacetylase 2 which is recruited by activated glucocorticoid receptors to switch off multiple proinfl ammatory genes.
In addition to these, recent insights into the mechanisms utilized by activated neutrophils to mobilize both intracellular and extracellular Ca 2+ , as well as to restore Ca 2+ homeostasis to the cells present a number of novel targets which are amenable to pharmacological control. In some cases target enhancement of activity improves the effi ciency of clearance of Ca 2+ from the cytosol, while in others this is achieved by target inhibition. Targets in the former category include endomembrane Ca 2+ ATP-ases, NADPH oxidase, myeloperoxidase, and protein kinase C, while in the latter category, phospholipase C, the Na 2+ /Ca 2+ exchanger, 5'-lipoxygenase, and store-operated Ca 2+ channels represent attractive targets.
Ca

2+ mobilization and restoration of Ca 2+ homeostasis as targets for neutrophil-directed antiinfl ammatory chemotherapy Inhibitors of phospholipase C
The importance of PLC as a potential target is underscored by the critical involvement of IP 3 , not only in mediating the release of Ca 2+ from intracellular stores, but also in sustaining elevations in cytosolic Ca 2+ by promoting shuttling of the cation between the stores and the cytosol (Anderson et al 2005) and possibly by initiating infl ux of Ca 2+ (Ma 2000; Bolotina 2004 ). Furthermore, diacylglycerol (DAG) generated by PLC activates protein kinase C (PKC), which in turn promotes the assembly and activation of NADPH oxidase (Tauber 1987 following release of the cation from storage vesicles (Anderson et al 1998; Tintinger et al 2001b) . The apparent sensitivity of PKA to cAMP has been exploited with the introduction of a wide range of pharmacologic agents, all of which share the ability to elevate intracellular cAMP concentrations. This can be achieved by several mechanisms, including activation of adenylate cyclase, or inhibition of phosphodiesterase enzymes (PDEs) responsible for the metabolism of cAMP (Moore and Willoughby 1995) . Adenylate cyclase is activated via G-protein-coupled receptors linked to membrane associated β-adrenergic, adenosine (A 2A ) and prostaglandin E 2 receptors. PDE isoenzymes of various classes have been identifi ed in neutrophils and PDE 4B2 is probably the most abundant of these (Wang et al 1999) . The relative tissue specifi city of PDE 4 isoenzymes for infl ammatory cells has enabled some degree of pharmacological targeting of neutrophils by new generation agents such as rofl imulast (Sanz et al 2007) and cilomilast (Baumer et al 2007) . The validity of this pharmacologic approach has been confi rmed in vitro as cAMP-elevating agents markedly suppress a range of Ca 2+ -dependent proinflammatory activities of neutrophils, including adhesion to vascular endothelium (Bloemen et al 1997) , oxidant production (Tintinger et al 2000) , as well as release of proteases, eicosanoids, and cytokines (Moore and Willoughby 1995; Tintinger et al 2000) . Furthermore, numerous clinical trials are ongoing or have been completed in which the effi cacy of these agents has been verifi ed in vivo (Pauwels et al 1997; Sullivan et al 2001; Vignola 2004) . Less well documented, however, is the role of cGMP during the restoration of Ca 2+ homeostasis in activated neutrophils. Intracellular cGMP concentrations can be increased by activation of guanylate cyclase, or by inhibition of PDEs that metabolize cGMP, predominantly PDEs 3 and 5 (Torphy 1998) . The endomembrane Ca 2+ -ATPase has been identifi ed as a putative target of cGMP acting via protein kinase G (Ay et al 2006) , although other mechanisms may exist whereby cGMP accelerates the clearance of cytosolic Ca 2+ . In this regard, cGMP may elevate intracellular cAMP levels by effectively acting as a competitive antagonist of PDE 3-mediated hydrolysis of cAMP (PDE 3 hydrolyzes both cyclic nucleotides) (BoswellSmith et al 2006) . The selective PDE 3 inhibitor, cilostazol, signifi cantly attenuated FMLP-mediated adhesion of neutrophils to human umbilical endothelial cells in vitro (Yang et al 2006) , and suppressed the cough threshold in elderly asthmatics (Ishiura et al 2005) .
Inhibitors of 5-Lipoxygenase
Leukotrienes, such as LTB 4 , are produced by activated neutrophils consequent to upregulation of the 5-lipoxygenase (5-LO) pathway (Peters-Golden and Henderson 2007). Phospholipase A 2 hydrolyzes membrane phospholipids liberating arachidonic acid, the substrate for 5-LO, and in the presence of calcium and 5-lipoxygenase-activating protein (FLAP), activated 5-LO generates leukotriene A 4 , which in neutrophils is converted to LTB 4 . The diverse role of LTB 4 in promoting infl ammation includes recruitment of infl ammatory cells (De Caterina and Zampolli 2004) , activation of cytosolic PLA 2 and degranulation (Boyce 2007), as well as the release of cytokines and matrix metalloproteinases, thus playing a role in immunoregulation (Rola-Pleszczynki et al 1986; Ford-Hutchinson 1990; Leppert et al 1995) . In addition to the physiological responses above, LTB 4 also participates in a positive feedback autocrine loop which activates phospholipase C and triggers sustained elevations of cytosolic Ca 2+ in PAF-activated neutrophils (McDonald et al 1994; Steel et al 2007) . Intracellular LTB 4 derived from 5-LO is actively transported to the cell exterior where it interacts with high affi nity LTB 4 receptors (BLT1) linked to PLC on the neutrophil plasma membrane. This interaction induces a secondary pulse of IP 3 which mediates sustained release of Ca 2+ into the cytosol and this in turn potentiates Ca 2+ -dependent pro-infl ammatory responses (Surette et al 1999; Steel et al 2007) .The validity of pharmacological anti-infl ammatory strategies targeting LTB 4 is underscored by recent evidence for the involvement of this leukotriene in the pathogenesis of bronchial asthma (De Caterina and Zampolli 2004) , COPD (Marian et al 2006) , and infl ammatory arthritis (Chen et al 2006) . Importantly, the imidazole antimycotic, itraconazole, antagonizes the effects of LTB 4 in PAF-activated neutrophils by inhibiting 5-LO (Steel et al 2007) . The concentrations of itraconazole required to inhibit 5-LO are similar to those achieved in the plasma of patients receiving this antimycotic (Kageyama et al 1999) . Interestingly, other agents in this class, fl uconazole and fl utrimazole, may also possess anti-infl ammatory properties as the former decreased mortality in critically ill patients by a mechanism unrelated to its antifungal properties (Jacobs et al 2003) , while the latter inhibited arachidonic acid-induced ear edema in a murine model (Merlos et al 1996) . Other 5-LO inhibitors such as zileuton, which inhibits production of both LTB 4 and the cysteinyl leukotrienes, LTC 4 and LTD 4, by activated eosinophils, have shown effi cacy in clinical trials of patients with bronchial asthma (Peters-Golden and Henderson 2007) . This is in keeping with the well established pathogenetic role of cysteinyl leukotrienes in infl ammatory airway diseases (Arm 2004) , and although neutrophils do not generate LTC 4 , or LTD 4 , receptors for cysteinyl leukotrienes, namely CysLT 1 and CysLT 2 are present on the plasma membrane of these cells. The physiological signifi cance of these receptors is unknown, but we have found recently that cysteinyl leukotrienes act as receptor-mediated priming agents for human neutrophils in vitro. Pretreatment of neutrophils with these agents augments the subsequent responses to FMLP with marked increases in oxidant production and elastase release compared with cells activated with the chemoattractant alone (unpublished observations). This fi nding is likely to be of importance given the widespread use of CysLT 1 receptor antagonists such as montelukast, pranlukast and zafi rlukast, all of which may modulate cysteinyl leukotriene-mediated priming of neutrophils in a clinical setting.
NADPH oxidase
The membrane-associated NADPH oxidase complex is assembled on the plasma membrane and becomes incorporated into the phagocytic vacuole following phagocytosis of microbial pathogens. When activated, the oxidase generates highly ROS by transferring electrons from NADPH to molecular oxygen. This electrogenic transfer of electrons results in signifi cant depolarization of the resting membrane potential. The oxygen radicals formed during this process include superoxide anions, hydroxyl radicals, hydrogen peroxide and hypochlorous acid (Nagata 2005) , all of which may participate in the killing of microbial pathogens. However, these toxic molecules have also been implicated in the pathogenesis of numerous diseases as their release to the extracellular environment may damage innocent bystander host tissues (Moraes et al 2006) . Although inhibition of the oxidase may abolish the generation of toxic ROS, this also abrogates the membrane depolarization response and dissipates the electrical gradient required to restrain Ca 2+ entry into leukocytes. Veritably, neutrophils lacking a functional oxidase such as those of patients with chronic granulomatous disease (CGD), are inherently predisposed to Ca 2+ overload (Tintinger et al 2001a; Rada et al 2003) with consequent exaggeration of Ca 2+ -dependent proinfl ammatory activity, including increased release of proteolytic enzymes (Tintinger et al 2001a) and cytokines (Bylund et al 2007) . NADPH oxidase thus fulfi lls dual roles as destroyer of microbial pathogens and in protecting the cell from Ca 2+ fl ooding of the cytosol mediated by its important membrane depolarizing action. Therefore, somewhat paradoxically, enhancing the activity of the oxidase may uncover unforeseen anti-infl ammatory properties (Hallett 2003; Hultqvist et al 2006) .
In addition to mediating membrane depolarization, recent evidence suggests that the oxidase also indirectly modulates the rate of neutrophil membrane repolarization . In this regard, myeloperoxidase (MPO) and hypochlorous acid have emerged as important regulators of the neutrophil membrane potential following activation of NADPH oxidase.
Myeloperoxidase and hypochlorous acid
Myeloperoxidase is stored in tertiary granules in the neutrophil cytosol and following the formation of phagocytic vacuoles is released into the phagosome, together with ROS generated from the concomitant activation of NADPH oxidase. Hydrogen peroxide thus formed acts as a substrate for MPO which catalyzes its conversion to the highly reactive oxidant, hypochlorous acid (HOCl). In the presence of MPO inhibitors such as sodium azide or 4-aminobenzoyl hydrazide (ABAH), the magnitude of neutrophil membrane depolarization in response to activating stimuli such as FMLP is not altered. However, the rate of recovery of the membrane potential is signifi cantly accelerated and this is associated with an increased rate and magnitude of Ca 2+ reuptake. Thus, inhibition of HOCl generation promotes rapid recovery of the membrane potential and accelerates the rate of capacitative Ca 2+ entry, underscoring the regulatory roles of MPO and HOCl during these events. This may paradoxically represent a physiological anti-infl ammatory activity of HOCl given the calcium requirements of numerous pro-infl ammatory neutrophil functions. Lending support to this contention, exaggerated infl ammatory responses have been observed in the skin and lungs of MPO-defi cient mice exposed to injurious ultraviolet light and irradiation, respectively (Milla et al 2004; Komatsu et al 2006) .
Inhibition of store-operated calcium channels
The IP 3 -mediated release of Ca 2+ from neutrophil storage vesicles is associated with activation of Ca 2+ entry channels on the plasma membrane of these cells in order to facilitate store refi lling. The mechanism of activation of these storeoperated channels (SOCCs) remains controversial, although recent evidence suggests a role for proteins Stim 1 and Orai 1 (Spassova et al 2006) . Given the elusive nature of the structure and mechanism/s of activation of these channels, it has been diffi cult to design pharmacologic inhibitors of SOCCs. However, the recent advances in our understanding of these channels, notably Stim 1 and Orai 1 (Putney 2007) , may pave the way for the development of agents that antagonize this mechanism of Ca 2+ reuptake. Regardless of the precise identity of, or coupling mechanisms that activate SOCCs, the rate of Ca 2+ entry through these channels is regulated by the electrochemical gradient for Ca 2+ across the plasma membrane (Geiszt et al 1997) . Accordingly, at depolarized potentials, Ca 2+ reuptake is opposed by the electrical gradient and is only initiated during the recovery phase of the membrane potential. Crucially, the rate of membrane repolarization is modulated by the activity of the plasma membrane Na + /Ca 2+ exchanger.
Inhibition of the Na + /Ca 2+ exchanger
The reverse mode of the Na + /Ca 2+ exchanger is activated by the rapid rise in cytosolic Ca 2+ consequent to release of the cation from stores. When operating in reverse mode, the exchanger extrudes 3 Na + ions for each Ca 2+ ion entering the cell (Blaustein and Lederer 1999) , with a resultant net loss of positive charge. Although proton effl ux from the cell is the primary charge compensating mechanism (Schrenzel et al 1998; Bánfi et al 1999) , the electrogenic Na + /Ca 2+ exchanger contributes to recovery of the membrane potential (Tintinger and Anderson 2004) and represents a target amenable to pharmacologic intervention. Inhibitors of the reverse mode of the Na + /Ca 2+ exchanger such as KB-R7943 markedly retard the rate of membrane repolarization with consequent attenuation of the rate and magnitude of Ca 2+ reuptake (Tintinger and Anderson 2004) . It is likely that delayed Ca 2+ entry with incomplete refi lling of Ca 2+ storage vesicles mediated by inhibitors of the exchanger may down-regulate the proinfl ammatory activity of neutrophils. Agents that inhibit the reverse mode of the Na + /Ca 2+ exchanger including KB-R7943 and SN-6 have shown promise in animal models of ischemia-reperfusion injury (Iwamato 2007), a condition in which activated neutrophils are considered to play a central pathogenetic role (Buras and Reenstra 2007) . Interestingly, the expression of Na
exchanger genes is upregulated in leukocytes from patients with cardiac failure (Seiler et al 2004) .
Conclusions
Advances in our understanding of the physiologic mechanisms pertaining to calcium handling by activated neutrophils have facilitated recognition of novel pharmacologic strategies designed to suppress the pro-infl ammatory activities of these cells. The distinct potential for agents such as imidazole antimycotics, antagonists of cysteinyl leukotriene receptors, inhibitors of the Na + /Ca 2+ exchanger, long-acting beta-adrenergic receptor agonists and phosphodiesterase inhibitors to modulate neutrophil-mediated infl ammation in vivo, creates exciting new opportunities for researchers in this important fi eld.
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